Utilizing Investigational Technologies in Oncology Trials
New technologies are changing oncology research – not only for cancer researchers but for patients. This paper explores the potential of liquid biopsies across diagnostics, therapy monitoring and disease recurrence from a clinical development point of view.
- The current state of the liquid biopsy market including commercial value and product development
- Analysis of liquid biopsy vs. traditional tissue biopsy
- Protocol implications for using liquid biopsy technologies in clinical studies
Submit this form for download.